No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Amgen and Fresenius Kabi Settle US BPCIA Denosumab Litigation
On 7 March 2025, the US District Court for the District of New Jersey ordered the dismissal of all claims and counterclaims in Amgen’s BPCIA patent infringement proceeding against Fresenius Kabi…